Skip to main content

Peer Review reports

From: Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study

Original Submission
14 Feb 2015 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
1 Oct 2015 Editorially accepted
8 Oct 2015 Article published 10.1186/s12885-015-1673-3

You can find further information about peer review here.

Back to article page